干扰素阿尔法康-1加上在严重急性呼吸综合征中的皮质类固醇:一项初步研究
Mona R Loutfy1, Lawrence M Blatt, Katharine A Siminovitch
1North York General Hospital, Toronto General Research Institute, Toronto, Ontario.
JAMA
|December 25, 2003
概括
干扰素阿尔法康-1与皮质类固醇结合在治疗严重急性呼吸系统综合征 (SARS) 中表现有前途. 这种SARS治疗改善了氧和和肺部愈合,因此需要进一步研究.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重急性呼吸系统综合征 (SARS) 成为一种新的临床挑战,没有确立的治疗策略.
- 迫切需要有效的治疗方法,突出了探索新治疗剂的重要性.
研究的目的:
- 评估SARS患者的干扰素阿尔法康-1与皮质类固醇结合的初步治疗益处和耐受性.
- 评估这种联合治疗对临床结果和疾病进展的影响.
主要方法:
- 这是一项开放性研究,涉及22名被诊断为可能患有SARS的患者.
- 患者接受了单独的皮质类固醇或皮质类固醇和皮下干扰素阿尔法康-1. 1的组合.
- 监测临床参数,包括氧和度,实验室标记和胸部X射线图.
主要成果:
- 干扰素阿尔法康-1组显示,肺异常的50%解消时间显著缩短 (4天而不是9天).
- 接受干扰素阿尔法康-1的患者表现出更好的氧和和更快的补充氧需求的解决方案.
- 与单独使用皮质类固醇相比,该组也表现出较少的肌酸激酶水平升高和更快的乳酸脱酶分解趋势.
结论:
- 初步发现表明,干扰素阿尔法康-1加上皮质类固醇可能对治疗SARS有好处.
- 这种组合疗法与改善的氧化,更快的放射性恢复和降低肌酸酶水平有关.
- 需要进一步调查,以确定干扰素阿尔法康-1在SARS治疗中的明确作用.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...